BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35422219)

  • 1. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors.
    Zhao Y; Che J; Tian A; Zhang G; Xu Y; Li S; Liu S; Wan Y
    Curr Cancer Drug Targets; 2022; 22(9):757-770. PubMed ID: 35422219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
    J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
    Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
    J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
    Huaqi Y; Caipeng Q; Qiang W; Yiqing D; Tao X
    Life Sci; 2019 Sep; 232():116614. PubMed ID: 31260682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
    Wang J; Shidfar A; Ivancic D; Ranjan M; Liu L; Choi MR; Parimi V; Gursel DB; Sullivan ME; Najor MS; Abukhdeir AM; Scholtens D; Khan SA
    Int J Cancer; 2017 Jun; 140(11):2484-2497. PubMed ID: 28263391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-asarone inhibits the migration, invasion, and EMT of bladder cancer through activating ER stress.
    Liu B; Dan W; Wei Y; Zhang Y; Wang C; Lei Y; Hou T; Zhang Y; Gao Y
    Cancer Med; 2023 Jun; 12(12):13610-13622. PubMed ID: 37306628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.
    Ding M; Zhan H; Liao X; Li A; Zhong Y; Gao Q; Liu Y; Huang W; Cai Z
    Int J Biol Sci; 2018; 14(10):1268-1276. PubMed ID: 30123075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
    Li C; Su H; Ruan C; Li X
    Folia Histochem Cytobiol; 2021; 59(1):40-48. PubMed ID: 33577073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
    Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
    Li J; Xu X; Meng S; Liang Z; Wang X; Xu M; Wang S; Li S; Zhu Y; Xie B; Lin Y; Zheng X; Liu B; Xie L
    Cell Death Dis; 2017 Aug; 8(8):e3010. PubMed ID: 28837140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
    Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
    Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
    Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma.
    He C; Wang Z; Zhang L; Yang L; Li J; Chen X; Zhang J; Chang Q; Yu Y; Liu B; Zhu Z
    Oncotarget; 2017 Jul; 8(29):46818-46833. PubMed ID: 28514754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
    Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
    Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.